Basit öğe kaydını göster

The pediatric rheumatology international trials organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus - Prospective validation of the disease activity core set

dc.contributor.authorPistorio, A
dc.contributor.authorUziel, Y
dc.contributor.authorMukamel, M
dc.contributor.authorRiley, P
dc.contributor.authorZulian, F
dc.contributor.authorOlivieri, AN
dc.contributor.authorCimaz, R
dc.contributor.authorGirschick, H
dc.contributor.authorRumba, I
dc.contributor.authorCavuto, S
dc.contributor.authorLovell, DJ
dc.contributor.authorMartini, A
dc.contributor.authorKasapcopur, O
dc.contributor.authorRuperto, N
dc.contributor.authorRavelli, A
dc.contributor.authorCuttica, R
dc.contributor.authorEspada, G
dc.contributor.authorOzen, S
dc.contributor.authorPorras, O
dc.contributor.authorSztajnbok, F
dc.contributor.authorFalcini, F
dc.contributor.authorVenning, H
dc.contributor.authorBica, B
dc.contributor.authorMerino, R
dc.contributor.authorCoto, C
dc.contributor.authorRos, J
dc.contributor.authorSusic, G
dc.contributor.authorGamir, ML
dc.contributor.authorMinden, K
dc.contributor.authorSee, Y
dc.date.accessioned2021-03-06T07:53:09Z
dc.date.available2021-03-06T07:53:09Z
dc.date.issued2005
dc.identifier.citationRuperto N., Ravelli A., Cuttica R., Espada G., Ozen S., Porras O., Sztajnbok F., Falcini F., Kasapcopur O., Venning H., et al., "The pediatric rheumatology international trials organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus - Prospective validation of the disease activity core set", ARTHRITIS AND RHEUMATISM, cilt.52, ss.2854-2864, 2005
dc.identifier.issn0004-3591
dc.identifier.otherav_de54a142-3ad1-44ac-a350-897954b1bb4e
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/146481
dc.identifier.urihttps://doi.org/10.1002/art.21230
dc.description.abstractObjective. To validate and promulgate a core set of outcome measures for the evaluation of response to treatment in patients with juvenile systemic lupus erythematosus (SLE).
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectİmmünoloji ve Romatoloji
dc.subjectİç Hastalıkları
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectROMATOLOJİ
dc.subjectKlinik Tıp
dc.subjectTıp
dc.titleThe pediatric rheumatology international trials organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus - Prospective validation of the disease activity core set
dc.typeMakale
dc.relation.journalARTHRITIS AND RHEUMATISM
dc.contributor.department, ,
dc.identifier.volume52
dc.identifier.issue9
dc.identifier.startpage2854
dc.identifier.endpage2864
dc.contributor.firstauthorID176216


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster